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Regional adiposity and markers 
of inflammation in pre-school age 
children
Kerri Z. Delaney  1,2,3, Catherine A. Vanstone4, Hope A. Weiler4 & Sylvia Santosa  1,2,3
In adults, upper body fat partially increases metabolic disease risk through increasing systemic 
inflammation. Our objective was to determine if this relationship exists in preschool-aged children. 
A subset of children (n = 71, 35 males), 3.7 ± 1.0 y, were studied from n = 515 children recruited 
from randomly selected daycares in Montréal, QC. According to WHO charts for 2–5 y, 49 children 
were healthy weight (HW) and 21 were overweight (OW). Adiposity was determined through dual-
energy x-ray absorptiometry. Blood concentrations of C-reactive protein (CRP) and tumour necrosis 
factor alpha (TNFα) were determined via enzyme-linked immunosorbent and multiplex assays, 
respectively. OW children had higher (p = 0.03) android:gynoid ratio 0.50 ± 0.09 compared to HW 
children 0.56 ± 0.12, indicating excess fat was predominantly stored in the abdominal depot. CRP 
was higher (p = 0.01) in OW children 1.45 ± 2.02 mg/L compared to HW 0.74 ± 1.38 mg/L. Percent 
fat was correlated with CRP (r = 0.32; p < 0.01) and TNFα (r = 0.25; p = 0.04) concentrations. CRP 
also correlated with android adiposity (r = 0.24; p = 0.04) and TNFα correlated with gynoid adiposity 
(r = 0.24; p = 0.04). We observed that greater adiposity is associated with higher systemic inflammation 
in pre-school aged children. Future longitudinal studies are needed to understand the long term 
consequences of excess total and regional body fat in young children.
Evidence shows that the increase in the incidence of overweight and obesity in adults is also occurring in pre-
school age children1. The most recent population-level assessment reporting on body mass index (BMI) in 
Canadian 2–5 year olds found approximately 17% were overweight or obese1. At this time, research examining 
the implications of carrying excess adipose tissue has been dominated by studies in adult populations with results 
from these studies often being extrapolated to children. However, these extrapolations come with limitations, 
as there are several physiological differences between children and adults. Studies conducted in children are 
required to accurately assess the implications of obesity in this population.
In adults, several studies have found a relationship between increased adipose tissue mass and systemic 
inflammatory markers2. This relationship is especially salient to upper body/android adipose tissue which has 
been described to be associated with greater inflammation than lower body/gynoid adipose tissue3,4. The greater 
inflammation observed in individuals with android obesity has been shown, in part, to contribute towards the 
greater risk for developing metabolic diseases including cardiovascular disease and type 2 diabetes5,6. A num-
ber of causes have been proposed for why this phenomenon occurs, most of which culminate in an increase in 
pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNFα) and C-reactive protein (CRP)7–9.
Although the positive relationship between increases in adipose tissue and systemic inflammation has 
been well established in adults10–13 and teenagers14–17, few studies have examined this relationship in youth 
6–12 years18,19 and young children 2–5 years20,21. Furthermore, to our knowledge, there has yet to be a study 
examining the association between regional adipose tissue mass and inflammation in children 2–5 years of age. 
The objective of this study was to determine if a relationship between whole body and regional adiposity and 
markers of inflammation exists in pre-school age children. We hypothesize that systemic inflammation will 
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increase with greater whole body mass and that there will be a stronger association between inflammation and 
android adiposity compared to gynoid adiposity.
Methods
Study Population and Protocol. This study examined a subset of preschoolers (n = 71) who underwent 
whole body fan-beam clinical dual-energy X-ray absorptiometry (DXA) scans. This subset was obtained from a 
larger sample of pre-school age children (n = 514, 2–5 years old) who were recruited from a random sample of 
licensed daycares in the greater Montreal area (n = 77). The daycares included represented 10% of the daycares 
registered with the Ministère de la Famille et des Ainès, (n = 733), which represents 91% of the Greater Montreal 
regions. Pamphlets outlining the details of the study were sent home to 8440 parents. Of these parents, 625 agreed 
to be contacted. After screening for eligibility over the telephone, 570 children were initially recruited to partic-
ipate in the study. Children were included if they were healthy and term born. Children were excluded if they 
had a disease causing disturbances of bone metabolism, known or suspected chronic illness of childhood, use 
of medication known to affect bone metabolism in the past 3 months, history of prior treatments for vitamin D 
deficiency, and severe anemia. Due to absences, lack of cooperation on the assessment days or insufficient sample 
volume, a final sample size of 514 children was obtained. A detailed description of participant inclusion has been 
previously described22.
Anthropometric measures and capillary blood samples were collected by a registered nurse who attended each 
daycare for the purposes of this study. All 514 children were invited for a DXA scan conducted by a trained per-
sonal at the Mary Emily Clinical Nutrition Research Unit, McGill University. Of the 514 children, 71 agreed to the 
DXA scan. When anthropometric and descriptive characteristics where compared, the 71 children who under-
went a DXA scan were not significantly different from the other 443 children except for in age, with the children 
who underwent a DXA scan being older (p = 0.001) than those who did not. All 71 DXA scans were successfully 
completed with no movement breaks in the images. Reports of recent physician visits were examined to exclude 
children with a recent illness and resulting elevated inflammation. Of the 71 children, two were excluded for 
having abnormally high levels of CRP and TNFα defined by greater than five standard deviations from the mean.
Ethics. The McGill University Faculty of Medicine Institutional Review Board approved this study and the 
secondary use of collected data. A parent or legal guardian provided written informed consent before the study. 
All measures were conducted in accordance to guidelines and regulations.
Anthropometric Measures and Body Composition. All anthropometric and body composition meas-
ures were taken while children were wearing light clothing (shorts and T-shirt) and no shoes. Height and weight 
was measured using standard procedures by a registered nurse at each daycare and by trained personnel at the 
Mary Emily Clinical Nutrition Research Unit on the day of each DXA scan22. Height was measured with a port-
able stadiometer (Seca 213, Seca Medical Scales and Measuring Systems, Hamburg, Germany) and body weight 
was measured with a digital scale (Home Collection 63-8711-0, Trileaf Distribution, Toronto, ON, Canada).
BMI was calculated as weight (kg)/ height (m)2. Children were divided by BMI percentiles according to World 
Health Organization charts for Canadian boys and girls, aged 2–19 years23. According to these charts, children 
were categorized as underweight (<3 percentile, n = 1), healthy weight (3–85 percentile, n = 49), or overweight 
(>85 percentile, n = 21) with no children falling into the obese category (>99 percentile). If children were clas-
sified using the CDC sex-specific BMI-for-age growth charts n = 6 children (3 males) would have been classified 
as obese.
To determine whole body and regional measures of adiposity, children underwent a whole body DXA scan 
(APEX version 13.2:3; Hologic, 2005, 4500A Discovery Series, Bedford, MA). After careful placement of whole 
body regions, the software automatically generates android and gynoid regions. The android region is defined 
with a lower limit of the iliac crest and upper limit set at 20% of the distance from the iliac crest to the base of the 
mandible. The gynoid region is defined with an upper limit of the iliac crest to an inferior distance that is 1.5 times 
the height of the android region.
Biochemical Assessment. A registered nurse collected 1 ml capillary blood samples by finger lance. All 
blood samples were collected between 0800 h and 1200 h and stored on ice between time of collection and arrival 
to the laboratory. At the laboratory, samples were centrifuged at 3000 g and 4 °C for 20 minutes. Plasma aliquots 
were stored at −80 °C until time of analysis.
Plasma CRP concentrations were measured using enzyme-linked immunosorbent assays (R&D Systems 
Quantikine, Minneapolis, Minn., USA; DRG International Inc., Mountainside, N.J., USA; Bachem, Bubendorf, 
Switzerland). Plasma TNFα concentration was measured using multiplex assay for small-volume samples (cat-
alog No. HMHMAG- 34 K, Millipore, Billerica, Mass., USA). There was no lower limit of detection (LOD) in 
the analysis of CRP. The LOD for TNFα with this assay was 0.3 pg/mL. If values were below the LOD they were 
reported as LOD/2 rather than zero. The average confidence interval on triplicate measurements (n = 30) was 
6.7% for CRP and 9.8% for TNFα.
Statistics. Data were first checked for normality using Shapiro-Wilks tests. Where possible non-parametric 
data was normalized using log transformations (total fat mass and android fat mass). CRP was not normally dis-
tributed and transformed data failed to meet the conditions of normality; thus non-parametric tests were used 
for this variable. Independent sample t-tests (parametric) and Mann-Whitney U (non-parametric) were used to 
compare differences between healthy and overweight children. A univariate analysis of variance (ANOVA) with 
Fisher’s least significant difference (LSD) post hoc was then used to test for differences in sex by weight categories. 
To test for the effect of covariates; sex and age, an analysis of covariance (ANCOVA) was run.
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To determine if correlations existed between regional and whole body measures of adiposity and markers of 
inflammation Pearson (parametric) and Spearman (non-parametric) correlations were conducted. To test for 
covariates; sex and age, a partial correlation test was used. Further covariates, race and household income, were 
examined however, are not reported as they did not affect the statistical analyses. Data were further split into 
healthy and overweight categories and correlations were run again to determine if the strength of any existing 
correlations changed. Studies that examine CRP and TNFα in children are limited. A study by Alvarez et al.19 
measured CRP and TNFα in overweight vs. lean children 7–12 y. Based on their measurements a mean difference 
and a standard deviation (SD) of 0.93 mg/L and 0.45 ng/mL, respectively in CRP, and 0.59 ng/mL and 0.66 ng/mL 
concentrations in TNFα is expected. Therefore, we would need 20–21 participants per group to detect a signifi-
cant difference at α = 0.05 and β = 0.80. All data were analyzed with SPSS v22 (Cary, NC). All data are presented 
as mean ± SD with p < 0.05 defined as significantly different.
Results
Participant Characteristics. Of the 71 children included in the study, the average age was 3.7 ± 1.0 years 
and 35 were male. The average BMI-for-age z-score was 0.04 ± 0.95 with the majority (n = 49) of children being 
healthy weight, between the 3rd and 85th percentiles. The average android:gynoid ratio and percent fat was 
0.52 ± 0.11 and 27.2 ± 5.1%, respectively.
When children were split into overweight and healthy weight categories, males comprised 57% (n = 12) of 
overweight and 47% (n = 23) of healthy weight children (Table 1). Healthy weight children were older than those 
who were overweight (p = 0.02; Table 1). BMI z-score, total fat mass and percent fat were significantly higher 
in overweight children (p < 0.01; Table 1). All measures of regional adiposity (android fat mass and gynoid fat 
mass) were significantly higher in overweight children (p < 0.01; Table 1). Overweight children had a signifi-
cantly greater android:gynoid ratio of 0.56 ± 0.12 compared to healthy weight children at 0.50 ± 0.09 (p = 0.03). 
Differences in the android:gynoid ratio between healthy and overweight children were no longer significant when 
sex, and age were controlled for.
Markers of Inflammation. Circulating concentration of CRP was significantly greater in overweight com-
pared to healthy weight children at 1.45 ± 2.02 mg/L and 0.74 ± 1.38 mg/L, respectively (p = 0.01; Table 1). When 
results were adjusted for sex they remained significant, however, when age was added to the model they were no 
longer significant. On average concentration of TNFα was greater in overweight children, with a trend (p = 0.06) 
towards significance, at 7.94 ± 3.18 ng/L compared to 6.85 ± 2.88 ng/L in healthy weight children (Table 1). This 
trend no longer existed when sex, and age were controlled for. Overweight males had significantly higher levels of 
TNFα than overweight females, and healthy weight males and females (p < 0.05).
Relationships between Whole and Regional Adiposity and Inflammation. Both CRP (r = 0.32; 
p < 0.01) and TNFα (r = 0.25; p = 0.04) were positively correlated with percent fat (Fig. 1). There were no cor-
relations between other whole body measures of adiposity (BMI, total fat mass) and markers of inflammation 
(Table 2). Android fat mass positively correlated with CRP (r = 0.24; p = 0.04) but not TNFα. In contrast, gynoid 
fat mass positively correlated with TNFα (r = 0.24; p = 0.04) but not CRP. All results remained significant when 
age and sex were controlled for. When children were divided into healthy and overweight categories, the strength 
of the correlation between CRP and percent fat increased to moderate at r = 0.62 (p < 0.01) in overweight chil-
dren. A negative correlation (r = −0.47, p < 0.05) between fat free mass and CRP was also observed in overweight 
children.
Discussion
To our knowledge this is the first study to examine the association between systemic markers of inflammation and 
regional and whole body adiposity in children 2–5 years of age. Our findings show children who were overweight 
had significantly higher levels of CRP than healthy weight counterparts. Furthermore, both CRP and TNFα pos-
itively correlated with percent fat mass with the correlation in CRP being stronger in overweight children. There 
were no clear associations between regional measures of adiposity and systemic markers of inflammation, with 
Variables
Healthy Weight 3rd-85th 
BMI° (n = 49)
Overweight > 85th 
BMI° (n = 21) p-value
Sex (M, F) 47%, 53% 57%, 43%
Age (years) 3.9 ± 0.9 3.3 ± 1.1 0.02
BMI z-score −0.37 ± 0.64 1.10 ± 0.54 <0.01
Percent Fat (%) 25.5 ± 3.8 31.3 ± 5.7 <0.01
Total Fat Mass (kg)† 4.3 ± 0.7 5.7 ± 1.2 <0.01
Android Fat Mass (g)† 189 ± 50 285 ± 116 <0.01
Gynoid Fat Mass (g) 777 ± 160 1042 ± 226 <0.01
Android:Gynoid 0.50 ± 0.09 0.56 ± 0.12 0.03
CRP (mg/L)a 0.74 ± 1.38* 1.45 ± 2.02 0.01
TNFα (ng/L) 6.85 ± 2.88* 7.94 ± 3.18 0.06
Table 1. Participant characteristics by weight category. Data are mean ± SD. P-value shown for Independent 
samples t-test or aMann-Whitney U unadjusted for sex and age. †log transformed, *n = 47.
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Figure 1. Pearson (TNFα) and Spearman (CRP) correlations between inflammatory markers and percent fat, 
android fat mass and gynoid fat mass. n = 68, -represents a correlation in the whole group; o represents healthy 
weight; x represents overweight.
Variables CRP (mg/L)a TNFα (ng/L)
BMI (kg/m2) 0.09 0.18
Total Fat Mass (kg)† 0.17 0.18
% Fat (%) 0.32** 0.25*
Android Fat Mass (g)† 0.24* 0.16
Gynoid Fat Mass (g) 0.20 0.24*
Android:Gynoid 0.09 −0.004
Table 2. Relationship between inflammatory markers and measures of adiposity. Data are Pearson (TNFα) or 
Spearman (CRP) correlation coefficients: *p < 0.05; **p < 0.01; n = 68. †log transformed. Controlled for age and sex.
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both the android and gynoid depot correlating with one marker of inflammation but not both. Before sex and age 
were controlled for, overweight children had a significantly greater android:gynoid ratio indicating excess adipose 
tissue was predominantly stored in the android region.
Higher levels of inflammation have previously been found in overweight youth14–19 and adults10–13 when com-
pared to healthy weight individuals however, few studies have examined this relationship in young children under 
the age of 5 years20,21. In adults, the increase in systemic inflammation resulting from excess adipose tissue has 
been linked to the development of type 2 diabetes and cardiovascular disease24,25. Circulating concentration of 
CRP is now used in clinical settings to determine the risk of a cardiovascular event in adults; a concentration of 
<1.0 mg/L indicating low risk, 1–3 mg/L moderate risk, and >3.0 mg/L high-risk26. In youth and children (1–17 
years), there is yet to be a clinically establish concentration for elevated CRP. Similarly, there is no clinically estab-
lished risk level of elevated TNFα in children or adults.
In our study, we found that compared to healthy weight counterparts, children who were overweight had 
increased concentrations of TNFα and double the concentration of circulating CRP. Our results are consistent with 
the study by Skinner et al.20 whose examination of NHANES data showed that very obese 3–5 year old children 
had a greater prevalence of high CRP. In our study, the positive age and sex adjusted correlations between percent 
fat mass and CRP and TNFα further supports that adipose tissue contributes to increases in these inflammatory 
markers. At this time, it cannot be said if elevated levels of systemic inflammation at a young age causes significant 
or lasting damage to the vascular system that would contribute to the development of cardiovascular disease in 
later life. Presently there is a lack of both cross sectional and longitudinal data following children throughout their 
development to know the effect of elevated adipose tissue mass and systemic inflammation in early years.
Utilizing DXA scans allowed for the accurate measure of whole body and regional body composition in study 
participants. Previous studies in children in the 2–5 year age range have relied on inferior methods to measure 
adiposity such as skin fold assessments, bio-electrical impedance analysis or waist: hip radio27. Overweight chil-
dren had a higher android:gynoid ratio than healthy weight children. The greater android:gynoid ratio indicates 
that children were predominantly storing excess adipose tissue in their abdominal depot. If this trend continues 
throughout their development, they could be at an increased risk for the early onset of metabolic disease28,29.
We found no distinct associations between android or gynoid adiposity and makers of inflammation as posi-
tive associations were observed between CRP and android fat mass, and TNFα and gynoid fat mass. In adults, the 
predominant storage of excess weight in the abdominal depot compared to the gynoid depot has been correlated 
with increased levels of circulatory inflammatory markers and increased risk of metabolic disease5,6. One reason 
for our observations may be that body morphology varies greatly between and within children as they grow and 
develop through these early years30. Likely, the relationship between elevated inflammation and abdominal adi-
posity does not occur until after the age of 5 as found by Staiano et al.31.
Since this study is cross sectional in design we are unable to delineate whether the differences in regional 
adipose tissue caused changes in inflammatory markers. The relationships we found in this study are important 
first steps towards understanding how adiposity affects inflammation in children. In our study, as defined by 
the World Health Organization charts for boys and girls, there were not any children with obesity. It is plausible 
that including children with obesity would have resulted in clearer associations between regional adiposity and 
inflammation. It should be noted, however, that there were significant differences in regional adipose tissue depot 
mass between the children with healthy and overweight, and there was a large range in regional fat depot masses 
within our study participants. According to the latest Statistics Canada report, the prevalence of overweight/
obesity in Quebec children in the 2–5 age range is 26.1%32.
In this study, we were unable to delineate between upper body subcutaneous and visceral adipose tissue mass. 
Though the direct quantification of visceral adipose tissue via MRI would have been ideal, the cost, access, and 
most importantly, difficulty in conducting an MRI scan in this age group was prohibitive. The use of the DXA 
in our study provided accurate measurement of total and regional fat depots. This is the first study of this scale 
to examine whole body DXA scans and inflammatory risk factors in young children. Future longitudinal studies 
should examine the long term risk associated with the weight driven increase in systemic inflammatory markers 
in young children. Specifically, the age of onset and the years of exposure to elevated levels of systemic inflamma-
tion should be examined. By furthering our knowledge in this area of study, we will be able to better understand 
the long term consequences of childhood obesity.
In conclusion, our study found young children in the 2–5 y age range had a weight associated increase in 
systemic inflammatory markers. Future longitudinal studies are needed to understand the long term conse-
quences of excess total and regional body fat in young children. Our results show, even in this age range, that 
children are negatively affected by carrying excess adipose tissue perpetuating the importance of early preven-
tion programs.
Data Availability
The datasets generated during and/or analyzed during the current study are not publicly available due to the 
inclusion of individuals who are minors but are available from the corresponding author on reasonable request.
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